Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7208 results

Applied Molecular Transport inks research and license agreement with Janssen on IBS therapy

Applied Molecular Transport inks research and license agreement with Janssen on IBS therapy

28-01-2015

Biopharma company Applied Molecular Transport has entered into a research collaboration and license agreement…

Applied Molecular TransportGastro-intestinalsJanssenJohnson & JohnsonLicensingPharmaceutical

US House Energy & Commerce Committee releases 21 Century Cures Act discussion draft

US House Energy & Commerce Committee releases 21 Century Cures Act discussion draft

28-01-2015

The promised January 2015 release of a discussion draft of legislation to implement the 21st Century…

PatentsPharmaceuticalPoliticsResearchUSA

Ferring appoints Pascal Danglas and Per Falk to senior positions

Ferring appoints Pascal Danglas and Per Falk to senior positions

28-01-2015

Switzerland-headquartered Ferring Pharmaceuticals has appointed Pascal Danglas as executive vice president…

BoardroomFerring PharmaceuticalsPascal DanglasPharmaceuticalSwitzerland

Roche’s 2014 profits miss forecasts, impacted by costs

Roche’s 2014 profits miss forecasts, impacted by costs

28-01-2015

Despite posting higher sales for full-year 2014, Swiss pharma major Roche missed analysts’ forecasts,…

FinancialPharmaceuticalReutersRocheUnited States

Russia may face shortage of anti-AIDS drugs in 2015

Russia may face shortage of anti-AIDS drugs in 2015

28-01-2015

Russia may face with a shortage of anti-AIDS drugs in 2015 due to the current complex situation in the…

Anti-viralsHealthcareMarkets & MarketingPharmaceuticalRussia

Biomay announces positive Phase IIb study of BM32 grass pollen vaccine

Biomay announces positive Phase IIb study of BM32 grass pollen vaccine

28-01-2015

Vienna-based allergy immunotherapy specialist Biomay has successfully completed a Phase IIb study of…

BiomayBM32ImmunologicalsPharmaceuticalResearchSwitzerland

Beximco Pharma borrows $51.5 million to fund expansion

28-01-2015

Bangladesh-based Beximco Pharmaceuticals has entered into a new loan agreement to borrow up to $51.559…

BangladeshBeximco PharmaBeximco PharmaceuticalsFinancialPharmaceutical

Amgen and Onyx submit Kyprolis sNDA and marketing authorization application in USA and EU

Amgen and Onyx submit Kyprolis sNDA and marketing authorization application in USA and EU

28-01-2015

USA-based Amgen, the world’s leading independent biotech firm, and its subsidiary Onyx Pharmaceuticals…

AmgenKyprolisOncologyOnyx PharmaceuticalsPharmaceuticalRegulationUSA

iCura Vision licenses macular degeneration portfolio from Columbia Technology Ventures

iCura Vision licenses macular degeneration portfolio from Columbia Technology Ventures

28-01-2015

Ophthalmic specialist iCura Vision has licensed the intellectual property portfolio and associated research…

iCura VisionLicensingOphthalmicsPharmaceuticalUSA

Fourth quarter Bristol-Myers Squibb results disappoint

Fourth quarter Bristol-Myers Squibb results disappoint

27-01-2015

Although the fourth quarter financial results from US drug major Bristol-Myers Squibb beat analyst estimates,…

Bristol-Myers SquibbFinancialPharmaceuticalUnited StatesUSA

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

27-01-2015

US pharma giant Pfizer today reported fourth-quarter 2014 earnings of $1.23 billion, and net earnings…

Corporate crimeDow Jones Industrial AverageFinancialPfizerPharmaceutical

Shire receives fast-track designation from FDA for SHP609 in Hunter syndrome

Shire receives fast-track designation from FDA for SHP609 in Hunter syndrome

27-01-2015

Ireland-headquartered drugmaker Shire has received fast-track designation from the US Food and Drug Administration…

NeurologicalPharmaceuticalRegulationShireSHP609

US FDA approves Symplmed and Servier’s Prestalia

US FDA approves Symplmed and Servier’s Prestalia

27-01-2015

Privately-held US drugmaker Symplmed Pharmaceuticals says that the US Food and Drug Administration has…

Cardio-vascularPharmaceuticalPrestaliaRegulationServierSymplmedUSA

T-Bird Pharma appoints Sandy Pratt as chief financial officer

T-Bird Pharma appoints Sandy Pratt as chief financial officer

27-01-2015

Canadian medical marijuana therapy specialist T-Bird Pharma has appointed Sandy Pratt as chief financial…

BoardroomCanadaPharmaceuticalT-Bird Pharma

MSF hits out at Pfizer's 'tiny' price reduction on Prevenar 13 in developing countries

MSF hits out at Pfizer's 'tiny' price reduction on Prevenar 13 in developing countries

27-01-2015

US pharma giant Pfizer has announced commitments to reduce the price of Prevenar 13 (pneumococcal polysaccharide…

Medecins Sans FrontiersPfizerPharmaceuticalPrevenarPricingVaccines

The FDA should innovate to respond to new health economy, says PwC survey

The FDA should innovate to respond to new health economy, says PwC survey

27-01-2015

Health care product manufacturers are now much more willing to have their products judged based on economic…

FDAFood and Drug AdministrationPharmaceuticalPwCRegulationUSA

Hybrigenics extends its partnership with Servier

27-01-2015

French biopharma company Hybrigenics says it has extended its partnership with France’s leading independent…

HybrigenicsOncologyPharmaceuticalResearchServier

Otsuka opens subsidiary in Australia

27-01-2015

Japanese drugmaker Otsuka Pharmaceutical has established a direct presence in Australia. A new office…

AustraliaManagementMarkets & MarketingNeurologicalOtsuka PharmaceuticalPharmaceutical

Novartis sees negative currency impact in 4th-qtr 2014; gives positive 2015 guidance

Novartis sees negative currency impact in 4th-qtr 2014; gives positive 2015 guidance

27-01-2015

Swiss pharma major Novartis, now the world’s largest drugmaker by sales, this morning posted financial…

FinancialNovartisPharmaceutical

Aspen buys rights to an anti-coagulant product from Novartis

26-01-2015

Aspen Global Inc, a wholly-owned subsidiary of South Africa’s Aspen Holdings, has entered into an agreement…

Aspen Global IncAspen HoldingsHematologyMergers & AcquisitionsMono-EmbolexNovartisPharmaceutical

Rockwell's Triferic cleared for marketing by US FDA

26-01-2015

The US Food and Drug Administration has approved US biopharma company Rockwell Medical’s Triferic (ferric…

Nephrology and HepatologyPharmaceuticalRegulationRockwell MedicalTrifericUSA

CIPA and KEFEA discuss initiatives to improve Cyprus’ pharma investment climate

26-01-2015

The potential to attract investments in the pharmaceutical industry and develop joint initiatives to…

FinancialHealthcarePharmaceuticalRest of the World

Nicox holds successful pre-NDA meeting with FDA for AC-170

Nicox holds successful pre-NDA meeting with FDA for AC-170

26-01-2015

French ophthalmics company Nicox has held a positive pre-New Drug Application meeting with the US Food…

AC-170NicOxOphthalmicsPharmaceuticalRegulationUSA

1 to 25 of 7208 results

Back to top